Search
Imexon
go.drugbank.com/drugs/DB05003InvestigationalImexon is a cyanoaziridine derivative. Imexon is a thiol-binding small molecule which induces mitochondrial oxidation, a loss of membrane potential and cytochrome C, leading to apoptosis. … Imexon is currently being studied for the treatment of pancreatic, lung, breast, prostate, melanoma, and multiple myeloma cancers. It belongs to the family of drugs called cyanoaziridine derivatives.
Tempol
go.drugbank.com/drugs/DB12449InvestigationalTempol has been used in trials studying the treatment of Anal Cancer.
Categories: Compounds used in a research, industrial, or household settingSynonyms: 4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl, 1-PIPERIDINYLOXY,4-HYDROXY-2,2,6,6-TETRAMETHYL-Hematoxylin
go.drugbank.com/drugs/DB16871ExperimentalCategories: Compounds used in a research, industrial, or household setting, Heterocyclic Compounds, 1-RingEfloxate
go.drugbank.com/drugs/DB13333ExperimentalCategories: Vasodilators Used in Cardiac Diseases, Heterocyclic Compounds, 1-RingTrolnitrate
go.drugbank.com/drugs/DB13719ExperimentalCategories: Vasodilators Used in Cardiac DiseasesMalachite Green
go.drugbank.com/drugs/DB03895ExperimentalSynonyms: malachite green(1+)Categories: Compounds used in a research, industrial, or household settingIndole-3-Glycerol Phosphate
go.drugbank.com/drugs/DB04143ExperimentalCategories: Compounds used in a research, industrial, or household settingSynonyms: Indole-3-Glycerol PhosphateBromopyruvate
go.drugbank.com/drugs/DB17135ExperimentalSynonyms: 3-bromo-2-oxopropanoic acid, 3-bromopyruvateCategories: Compounds used in a research, industrial, or household settingRiferminogene pecaplasmid
go.drugbank.com/drugs/DB06394InvestigationalRiferminogene pecaplasmid (non-viral fibroblast growth factor 1; NV1FGF) is a recombinant DNA plasmid in a pCOR backbone allowing expression of human FGF1.
Synonyms: Non-viral fibroblast growth factor 1DP-VPA
go.drugbank.com/drugs/DB05821InvestigationalDP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure